Joerg C. Schefold
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (29)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Background Women are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown. Aim We assessed the impact of sex and gender on PASC in a Swiss population. Method Our multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection. Results Among those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41–1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03–1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74–1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01–1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03–1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29–2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60–0.97; p = 0.030). Conclusion Specific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (25)
Catherine Gebhard
University of Zurich
Ulrich Goebel
Head of Department
-
Theis Lange
Københavns Universitet
Marie-Madlen Jeitziner
University Hospital of Bern
Hazem Abosheaishaa
-
Timo Mayerhöfer
Medical University of Innsbruck
Anders Granholm
Copenhagen University Hospital
Caroline E. Gebhard
University Hospital Basel
Silvio Daniel Brugger
University of Zurich
Marc Moritz Berger
University Hospital Essen
René Müri
University of Bern
Thomas Lass Klitgaard
Aalborg University
Rebecka Rubenson Wahlin
Karolinska Institutet
Valerie Treyer
-
Maria Flamm
-
Jørn Wetterslev
Chief Physician
Copenhagen University Hospital
NAWFEL BEN-HAMOUDA
Senior lecturer
University of Lausanne
Daniel G Fuster
-
Georg Goebel
Associate Professor
Medical University of Innsbruck
Jesper Fjølner
Aarhus University
David I. Radke
University Hospital Schleswig-Holstein
Ingeborg Welters
University of Liverpool
Johannes Bastian
Prof. Dr. med.; Senior Consultant Hip and Pelvis Surgeon, Co-Head Orthogeriatric Center
-
Harald Burgsteiner
Professor
University of Teacher Education Styria
Carmen Andrea Pfortmueller
Deputy Chief Physician
Inselspital Universitätsspital Bern
Make your next move.
Prepare your application
Review drafts before you send them.